SEC Form 4 · accession 0001144204-16-112317
TG THERAPEUTICS, INC. · TGTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth Hoberman
Director
Period of report
Jul 6, 2016
Accepted (ET)
Jul 8, 2016 · 8:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001001316
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCKF2 | Jul 6, 2016 | A | 12,459 | $0.00 | A | 86,905 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects a grant of restricted shares that will vest on June 14, 2019.
- F2Includes 5,556 warrants to purchase Common Stock at $2.25, exercisable through January 31, 2017.